182 related articles for article (PubMed ID: 15107145)
1. Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.
Gustafson RA; Kim I; Stout PR; Klette KL; George MP; Moolchan ET; Levine B; Huestis MA
J Anal Toxicol; 2004 Apr; 28(3):160-7. PubMed ID: 15107145
[TBL] [Abstract][Full Text] [Related]
2. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults.
Schlienz NJ; Cone EJ; Herrmann ES; Lembeck NA; Mitchell JM; Bigelow GE; Flegel R; LoDico CP; Hayes ED; Vandrey R
J Anal Toxicol; 2018 May; 42(4):232-247. PubMed ID: 29300962
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
Huestis MA; Mitchell JM; Cone EJ
J Anal Toxicol; 1996 Oct; 20(6):441-52. PubMed ID: 8889681
[TBL] [Abstract][Full Text] [Related]
5. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
[TBL] [Abstract][Full Text] [Related]
6. Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans.
Gustafson RA; Levine B; Stout PR; Klette KL; George MP; Moolchan ET; Huestis MA
Clin Chem; 2003 Jul; 49(7):1114-24. PubMed ID: 12816908
[TBL] [Abstract][Full Text] [Related]
7. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
[TBL] [Abstract][Full Text] [Related]
8. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.
Lowe RH; Abraham TT; Darwin WD; Herning R; Cadet JL; Huestis MA
Drug Alcohol Depend; 2009 Nov; 105(1-2):24-32. PubMed ID: 19631478
[TBL] [Abstract][Full Text] [Related]
9. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations.
Huestis MA; Elsohly M; Nebro W; Barnes A; Gustafson RA; Smith ML
Ther Drug Monit; 2006 Aug; 28(4):540-4. PubMed ID: 16885722
[TBL] [Abstract][Full Text] [Related]
10. Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.
Schwilke EW; Schwope DM; Karschner EL; Lowe RH; Darwin WD; Kelly DL; Goodwin RS; Gorelick DA; Huestis MA
Clin Chem; 2009 Dec; 55(12):2180-9. PubMed ID: 19833841
[TBL] [Abstract][Full Text] [Related]
11. Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users.
Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
J Anal Toxicol; 2020 Jan; 44(1):1-14. PubMed ID: 31095692
[TBL] [Abstract][Full Text] [Related]
12. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
13. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users.
Smith-Kielland A; Skuterud B; Mørland J
J Anal Toxicol; 1999 Sep; 23(5):323-32. PubMed ID: 10488918
[TBL] [Abstract][Full Text] [Related]
15. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans.
Huestis MA; Cone EJ
Ther Drug Monit; 1998 Oct; 20(5):570-6. PubMed ID: 9780137
[TBL] [Abstract][Full Text] [Related]
17. Elimination of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol when normalized to urinary creatinine.
Beardsley GD; Christensen JM
Res Commun Mol Pathol Pharmacol; 2007-2008; 120-121(1-6):67-78. PubMed ID: 21469505
[TBL] [Abstract][Full Text] [Related]
18. Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users.
Schwilke EW; Gullberg RG; Darwin WD; Chiang CN; Cadet JL; Gorelick DA; Pope HG; Huestis MA
Addiction; 2011 Mar; 106(3):499-506. PubMed ID: 21134021
[TBL] [Abstract][Full Text] [Related]
19. Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.
Schuster RM; Potter K; Vandrey R; Hareli M; Gilman J; Schoenfeld D; Evins AE
J Psychopharmacol; 2020 Feb; 34(2):197-210. PubMed ID: 31535597
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid concentrations in hair from documented cannabis users.
Huestis MA; Gustafson RA; Moolchan ET; Barnes A; Bourland JA; Sweeney SA; Hayes EF; Carpenter PM; Smith ML
Forensic Sci Int; 2007 Jul; 169(2-3):129-36. PubMed ID: 16963215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
